A comprehensive view of Generics / Biosimilars. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Cardinal Health releases 2024 Biosimilars Report, offering insights on the growing impact of biosimilars on healthcare affordability and patient accessibility; research highlights advances in treatments

Teva to divest its TAPI global small-molecule API business to refocus on capital reallocation and growth strategies; the divestiture is expected to complete in first half of 2025 and could be worth around US$2.0B

Alvotech to launch Stelara biosimilar AVT04 after securing settlement deal with J&J; biosimilar to be launched in Japan, Canada and European Economic Area

FTC and HHS to investigate pharmaceutical chain middlemen's business practices possibly contributing to drug shortages; seek stakeholder input on market concentration and contracting methods, with a decision due in mid-April

FTC and HHS launch joint request for information on practices of drug wholesalers and group purchasing organizations and their potential impact on access to and pricing of generic pharmaceuticals; the inquiry aims to identify root causes of drug shortages

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count